Last reviewed · How we verify

Physioneal 35

University of Erlangen-Nürnberg Medical School · FDA-approved active Small molecule

Physioneal 35 is a peritoneal dialysis fluid formulated to optimize electrolyte balance and reduce peritoneal membrane injury during dialysate exchange.

Physioneal 35 is a peritoneal dialysis fluid formulated to optimize electrolyte balance and reduce peritoneal membrane injury during dialysate exchange. Used for Peritoneal dialysis in end-stage renal disease (ESRD).

At a glance

Generic namePhysioneal 35
Also known asNephropaed-PD-01/B
SponsorUniversity of Erlangen-Nürnberg Medical School
Drug classPeritoneal dialysis solution
ModalitySmall molecule
Therapeutic areaNephrology
PhaseFDA-approved

Mechanism of action

Physioneal 35 is a bicarbonate-buffered peritoneal dialysis solution designed to improve biocompatibility compared to conventional lactate-buffered solutions. It contains a physiologic electrolyte composition and uses bicarbonate as the primary buffer, which reduces glucose degradation products and advanced glycation end products (AGEs) that can damage the peritoneal membrane. This formulation aims to preserve peritoneal function and reduce inflammation during long-term peritoneal dialysis treatment.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results